Study to Assess Change in Disease Symptoms in Adult Participants With Moderate to Severe Psoriasis Treated With Subcutaneous Risankizumab Injection According to Standard of Care
Clinical trial NCT04780516 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04780516
- Sponsor
- AbbVie
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2021-04-26
- Primary completion
- 2024-01-02
- Enrollment
- 141
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.